Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	inhibitory extracellular ligand-gated monoatomic ion channel activity	GLRA3 GLRA1 GABRA6	6.31e-06	8	98	3	GO:0005237
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	SMARCA5 CHD2 CHD7 INO80	3.18e-05	37	98	4	GO:0140658
GeneOntologyMolecularFunction	ribonucleoside-diphosphate reductase activity	RRM2B RRM1	7.13e-05	3	98	2	GO:0061731
GeneOntologyMolecularFunction	ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor	RRM2B RRM1	7.13e-05	3	98	2	GO:0004748
GeneOntologyMolecularFunction	lactoperoxidase activity	PXDNL LPO	1.42e-04	4	98	2	GO:0140825
GeneOntologyMolecularFunction	oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor	RRM2B RRM1	2.36e-04	5	98	2	GO:0016728
GeneOntologyMolecularFunction	extracellularly glycine-gated ion channel activity	GLRA3 GLRA1	3.53e-04	6	98	2	GO:0016933
GeneOntologyMolecularFunction	extracellularly glycine-gated chloride channel activity	GLRA3 GLRA1	3.53e-04	6	98	2	GO:0016934
GeneOntologyMolecularFunction	chloride transmembrane transporter activity	GLRA3 CLIC6 SLC6A1 GLRA1 GABRA6	3.78e-04	125	98	5	GO:0015108
GeneOntologyMolecularFunction	prolactin receptor binding	CSH1 CSH2	4.93e-04	7	98	2	GO:0005148
GeneOntologyMolecularFunction	chloride channel activity	GLRA3 CLIC6 GLRA1 GABRA6	8.51e-04	86	98	4	GO:0005254
GeneOntologyMolecularFunction	monoatomic anion transmembrane transporter activity	GLRA3 CLIC6 SLC6A1 GLRA1 GABRA6	8.93e-04	151	98	5	GO:0008509
GeneOntologyMolecularFunction	growth hormone receptor binding	CSH1 CSH2	1.05e-03	10	98	2	GO:0005131
GeneOntologyMolecularFunction	channel activity	SLC24A5 GLRA3 BCL2 CLIC6 KCNB2 PIEZO2 GLRA1 TRPV3 GABRA6	1.11e-03	525	98	9	GO:0015267
GeneOntologyMolecularFunction	passive transmembrane transporter activity	SLC24A5 GLRA3 BCL2 CLIC6 KCNB2 PIEZO2 GLRA1 TRPV3 GABRA6	1.12e-03	526	98	9	GO:0022803
GeneOntologyMolecularFunction	clathrin heavy chain binding	GPR107 CEMIP	1.52e-03	12	98	2	GO:0032050
GeneOntologyMolecularFunction	inorganic anion transmembrane transporter activity	GLRA3 CLIC6 SLC6A1 GLRA1 GABRA6	1.55e-03	171	98	5	GO:0015103
GeneOntologyMolecularFunction	monoatomic anion channel activity	GLRA3 CLIC6 GLRA1 GABRA6	1.66e-03	103	98	4	GO:0005253
GeneOntologyMolecularFunction	monoatomic ion channel activity	SLC24A5 GLRA3 CLIC6 KCNB2 PIEZO2 GLRA1 TRPV3 GABRA6	1.90e-03	459	98	8	GO:0005216
GeneOntologyMolecularFunction	ligand-gated monoatomic anion channel activity	GLRA3 GLRA1 GABRA6	1.90e-03	50	98	3	GO:0099095
GeneOntologyMolecularFunction	BH domain binding	BCL2 BIK	2.09e-03	14	98	2	GO:0051400
GeneOntologyMolecularFunction	glycine binding	GLRA3 GLRA1	2.09e-03	14	98	2	GO:0016594
GeneOntologyMolecularFunction	oxidoreductase activity, acting on CH or CH2 groups	RRM2B RRM1	2.40e-03	15	98	2	GO:0016725
GeneOntologyBiologicalProcess	carbohydrate derivative biosynthetic process	NPC1 ACACB RRM2B ELOVL1 ARFGEF1 BCL2 ST3GAL3 RRM1 ABCA7 ALG10B CEMIP TMEM260 PIGA MOGS A4GNT B3GAT2	3.64e-07	736	98	16	GO:1901137
GeneOntologyBiologicalProcess	positive regulation of multicellular organism growth	BCL2 CHD7 CSH1 CSH2 DIO3	2.86e-06	47	98	5	GO:0040018
GeneOntologyBiologicalProcess	glycoprotein biosynthetic process	NPC1 ARFGEF1 BCL2 ST3GAL3 ABCA7 ALG10B TMEM260 MOGS A4GNT B3GAT2	7.72e-06	357	98	10	GO:0009101
GeneOntologyBiologicalProcess	macromolecule glycosylation	NPC1 ARFGEF1 ST3GAL3 ALG10B TMEM260 MOGS A4GNT B3GAT2	2.71e-05	252	98	8	GO:0043413
GeneOntologyBiologicalProcess	protein glycosylation	NPC1 ARFGEF1 ST3GAL3 ALG10B TMEM260 MOGS A4GNT B3GAT2	2.71e-05	252	98	8	GO:0006486
GeneOntologyBiologicalProcess	glycoprotein metabolic process	NPC1 ARFGEF1 BCL2 ST3GAL3 ABCA7 ALG10B TMEM260 MOGS A4GNT B3GAT2	3.82e-05	430	98	10	GO:0009100
GeneOntologyBiologicalProcess	glycosylation	NPC1 ARFGEF1 ST3GAL3 ALG10B TMEM260 MOGS A4GNT B3GAT2	4.42e-05	270	98	8	GO:0070085
GeneOntologyBiologicalProcess	regulation of multicellular organism growth	BCL2 CHD7 CSH1 CSH2 DIO3	8.16e-05	93	98	5	GO:0040014
GeneOntologyBiologicalProcess	chloride transmembrane transport	GLRA3 CLIC6 SLC6A1 GLRA1 GABRA6	1.96e-04	112	98	5	GO:1902476
GeneOntologyBiologicalProcess	carbohydrate derivative metabolic process	NPC1 ACACB RRM2B ELOVL1 ARFGEF1 BCL2 ST3GAL3 RRM1 ABCA7 ALG10B CEMIP TMEM260 PIGA MOGS A4GNT B3GAT2	2.06e-04	1226	98	16	GO:1901135
GeneOntologyBiologicalProcess	positive regulation of growth	ACACB BCL2 CHD7 INO80 PTK2 CSH1 CSH2 DIO3	2.14e-04	339	98	8	GO:0045927
GeneOntologyBiologicalProcess	endocardial cushion fusion	CPLANE2 ACVR1	2.21e-04	5	98	2	GO:0003274
GeneOntologyBiologicalProcess	growth hormone receptor signaling pathway	PTK2 CSH1 CSH2	2.50e-04	26	98	3	GO:0060396
GeneOntologyBiologicalProcess	cellular response to growth hormone stimulus	PTK2 CSH1 CSH2	2.80e-04	27	98	3	GO:0071378
GeneOntologyCellularComponent	ribonucleoside-diphosphate reductase complex	RRM2B RRM1	6.51e-05	3	98	2	GO:0005971
GeneOntologyCellularComponent	chloride channel complex	GLRA3 CLIC6 GLRA1 GABRA6	1.48e-04	57	98	4	GO:0034707
GeneOntologyCellularComponent	growth hormone receptor complex	CSH1 CSH2	3.22e-04	6	98	2	GO:0070195
GeneOntologyCellularComponent	trans-Golgi network	SLC24A5 ARFGEF1 VPS54 CSH1 CSH2 ATP2C2 ECE2	5.97e-04	306	98	7	GO:0005802
MousePheno	delayed vaginal opening	MAGEL2 CHD7 CSH1 CSH2	1.74e-05	28	79	4	MP:0002636
MousePheno	abnormal timing of vaginal opening	MAGEL2 CHD7 CSH1 CSH2	2.65e-05	31	79	4	MP:0020150
MousePheno	pale kidney	COL4A3 RRM2B CHD2 BCL2	3.41e-05	33	79	4	MP:0004969
Domain	SNF2_N	SMARCA5 CHD2 CHD7 INO80	2.20e-05	32	97	4	IPR000330
Domain	SNF2_N	SMARCA5 CHD2 CHD7 INO80	2.20e-05	32	97	4	PF00176
Domain	DBINO	SMARCA5 INO80	7.98e-05	3	97	2	PF13892
Domain	DBINO	SMARCA5 INO80	7.98e-05	3	97	2	IPR020838
Domain	Lipase_GDXG_put_SER_AS	AADAC NCEH1	1.59e-04	4	97	2	IPR033140
Domain	Glycine_rcpt_A	GLRA3 GLRA1	1.59e-04	4	97	2	IPR008127
Domain	Arylacetamide_deacetylase	AADAC NCEH1	1.59e-04	4	97	2	IPR017157
Domain	Lipase_GDXG_HIS_AS	AADAC NCEH1	1.59e-04	4	97	2	IPR002168
Domain	GABAA/Glycine_rcpt	GLRA3 GLRA1 GABRA6	2.23e-04	23	97	3	IPR006028
Domain	PEROXIDASE_1	PXDNL LPO	3.95e-04	6	97	2	PS00435
Domain	SOMATOTROPIN_2	CSH1 CSH2	3.95e-04	6	97	2	PS00338
Domain	Hormone_1	CSH1 CSH2	3.95e-04	6	97	2	PF00103
Domain	LIPASE_GDXG_SER	AADAC NCEH1	3.95e-04	6	97	2	PS01174
Domain	LIPASE_GDXG_HIS	AADAC NCEH1	3.95e-04	6	97	2	PS01173
Domain	SOMATOTROPIN_1	CSH1 CSH2	3.95e-04	6	97	2	PS00266
Domain	Somatotropin	CSH1 CSH2	5.51e-04	7	97	2	IPR001400
Domain	AB_hydrolase_3	AADAC NCEH1	5.51e-04	7	97	2	IPR013094
Domain	Abhydrolase_3	AADAC NCEH1	5.51e-04	7	97	2	PF07859
Domain	Bcl2_BH3_motif_CS	BCL2 BIK	7.32e-04	8	97	2	IPR020728
Domain	DNA/RNA_helicase_DEAH_CS	SMARCA5 CHD2 CHD7	7.88e-04	35	97	3	IPR002464
Domain	Biotin_lipoyl	ACACB DBT	9.39e-04	9	97	2	PF00364
Domain	DEAH_ATP_HELICASE	SMARCA5 CHD2 CHD7	1.00e-03	38	97	3	PS00690
Domain	Haem_peroxidase	PXDNL LPO	1.17e-03	10	97	2	IPR010255
Domain	An_peroxidase	PXDNL LPO	1.17e-03	10	97	2	PF03098
Domain	PEROXIDASE_3	PXDNL LPO	1.17e-03	10	97	2	PS50292
Domain	Haem_peroxidase_animal	PXDNL LPO	1.17e-03	10	97	2	IPR019791
Domain	Biotin_lipoyl	ACACB DBT	1.17e-03	10	97	2	IPR000089
Domain	BIOTINYL_LIPOYL	ACACB DBT	1.17e-03	10	97	2	PS50968
Domain	-	PXDNL LPO	1.17e-03	10	97	2	1.10.640.10
Domain	Neurotransmitter_ion_chnl_CS	GLRA3 GLRA1 GABRA6	1.65e-03	45	97	3	IPR018000
Domain	Single_hybrid_motif	ACACB DBT	1.70e-03	12	97	2	IPR011053
Domain	Neur_chan_memb	GLRA3 GLRA1 GABRA6	1.75e-03	46	97	3	PF02932
Domain	Neur_chan_LBD	GLRA3 GLRA1 GABRA6	1.87e-03	47	97	3	PF02931
Domain	NEUROTR_ION_CHANNEL	GLRA3 GLRA1 GABRA6	1.87e-03	47	97	3	PS00236
Domain	Neurotrans-gated_channel_TM	GLRA3 GLRA1 GABRA6	1.87e-03	47	97	3	IPR006029
Domain	-	GLRA3 GLRA1 GABRA6	1.87e-03	47	97	3	2.70.170.10
Domain	Neur_channel	GLRA3 GLRA1 GABRA6	1.87e-03	47	97	3	IPR006201
Domain	Neur_chan_lig-bd	GLRA3 GLRA1 GABRA6	1.87e-03	47	97	3	IPR006202
Domain	Helicase_C	SMARCA5 CHD2 CHD7 INO80	2.34e-03	107	97	4	PF00271
Domain	HELICc	SMARCA5 CHD2 CHD7 INO80	2.34e-03	107	97	4	SM00490
Domain	Helicase_C	SMARCA5 CHD2 CHD7 INO80	2.43e-03	108	97	4	IPR001650
Domain	HELICASE_CTER	SMARCA5 CHD2 CHD7 INO80	2.51e-03	109	97	4	PS51194
Domain	HELICASE_ATP_BIND_1	SMARCA5 CHD2 CHD7 INO80	2.51e-03	109	97	4	PS51192
Domain	DEXDc	SMARCA5 CHD2 CHD7 INO80	2.51e-03	109	97	4	SM00487
Domain	Helicase_ATP-bd	SMARCA5 CHD2 CHD7 INO80	2.59e-03	110	97	4	IPR014001
Domain	BH3	BCL2 BIK	3.45e-03	17	97	2	PS01259
Pubmed	Characterization of the glycinergic input to bipolar cells of the mouse retina.	GLRA3 GLRA1	8.02e-06	2	99	2	16420443
Pubmed	Investigation of the association of hRRM1 and p53R2 gene polymorphisms in head and neck squamous cell carcinomas.	RRM2B RRM1	8.02e-06	2	99	2	24861915
Pubmed	Phosphorylation of α3 glycine receptors induces a conformational change in the glycine-binding site.	GLRA3 GLRA1	8.02e-06	2	99	2	23834509
Pubmed	A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage.	RRM2B RRM1	8.02e-06	2	99	2	10716435
Pubmed	Bcl-2 sensitivity differentiates two pathways for motoneuronal death in the wobbler mutant mouse.	BCL2 VPS54	8.02e-06	2	99	2	8815872
Pubmed	Identification of the interchain disulfide bonds of dimeric human placental lactogen.	CSH1 CSH2	8.02e-06	2	99	2	438159
Pubmed	Ribonucleotide Reductase Requires Subunit Switching in Hypoxia to Maintain DNA Replication.	RRM2B RRM1	8.02e-06	2	99	2	28416140
Pubmed	Amino acid sequence of human chorionic somatomammotropin.	CSH1 CSH2	8.02e-06	2	99	2	4712450
Pubmed	Association study of ABCA7 and NPC1 polymorphisms with Alzheimer's disease in Chinese Han ethnic population.	NPC1 ABCA7	8.02e-06	2	99	2	24064683
Pubmed	Two structurally different genes produce the same secreted human placental lactogen hormone.	CSH1 CSH2	8.02e-06	2	99	2	6300056
Pubmed	Proapoptotic BH3-only Bcl-2 family member Bik/Blk/Nbk is expressed in hemopoietic and endothelial cells but is redundant for their programmed death.	BCL2 BIK	8.02e-06	2	99	2	14749373
Pubmed	Cotranslational sequestration of egg white proteins and placental lactogen inside membrane vesicles.	CSH1 CSH2	8.02e-06	2	99	2	6930851
Pubmed	Multifunctional basic motif in the glycine receptor intracellular domain induces subunit-specific sorting.	GLRA3 GLRA1	8.02e-06	2	99	2	19959465
Pubmed	Analysis of a major human chorionic somatomammotropin gene. Evidence for two functional promoter elements.	CSH1 CSH2	8.02e-06	2	99	2	6208192
Pubmed	Probing glycine receptor stoichiometry in superficial dorsal horn neurones using the spasmodic mouse.	GLRA3 GLRA1	8.02e-06	2	99	2	21486794
Pubmed	Multiple origins of transcription for the human placental lactogen genes.	CSH1 CSH2	8.02e-06	2	99	2	6209277
Pubmed	Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine.	RRM2B RRM1	8.02e-06	2	99	2	24215511
Pubmed	The motoneuron degeneration in the wobbler mouse is independent of the overexpression of a Bcl2 transgene in neurons.	BCL2 VPS54	8.02e-06	2	99	2	8577388
Pubmed	p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint.	RRM2B RRM1	8.02e-06	2	99	2	11719458
Pubmed	Amino-acid sequence of human placental lactogen.	CSH1 CSH2	8.02e-06	2	99	2	5286363
Pubmed	Possible involvement of the vascular endothelial growth factor-Flt-1-focal adhesion kinase pathway in chemotaxis and the cell proliferation of osteoclast precursor cells in arthritic joints.	FLT1 PTK2	8.02e-06	2	99	2	12023386
Pubmed	Construction and analysis of recombinant DNA for human chorionic somatomammotropin.	CSH1 CSH2	8.02e-06	2	99	2	593368
Pubmed	A domain-specific usherin/collagen IV interaction may be required for stable integration into the basement membrane superstructure.	COL4A3 USH2A	2.40e-05	3	99	2	14676276
Pubmed	Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion.	RRM2B RRM1	2.40e-05	3	99	2	17486094
Pubmed	Differential placental expression profile of human Growth Hormone/Chorionic Somatomammotropin genes in pregnancies with pre-eclampsia and gestational diabetes mellitus.	CSH1 CSH2	2.40e-05	3	99	2	22387044
Pubmed	Novel mechanism of anti-apoptotic function of 78-kDa glucose-regulated protein (GRP78): endocrine resistance factor in breast cancer, through release of B-cell lymphoma 2 (BCL-2) from BCL-2-interacting killer (BIK).	BCL2 BIK	2.40e-05	3	99	2	21622563
Pubmed	Focal adhesion kinase, paxillin, and bcl-2: analysis of expression, phosphorylation, and association during morphogenesis.	BCL2 PTK2	2.40e-05	3	99	2	10417825
Pubmed	Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains.	BCL2 BIK	2.40e-05	3	99	2	9488477
Pubmed	Lewis y enhances CAM-DR in ovarian cancer cells by activating the FAK signaling pathway and upregulating Bcl-2/Bcl-XL expression.	BCL2 PTK2	2.40e-05	3	99	2	25726913
Pubmed	G-quadruplexes in the BAP1 promoter positively regulate its expression.	CHD2 CHD7	2.40e-05	3	99	2	29787736
Pubmed	Diversity of glycine receptors in the mouse retina: localization of the alpha4 subunit.	GLRA3 GLRA1	2.40e-05	3	99	2	17154252
Pubmed	Glycinergic input of small-field amacrine cells in the retinas of wildtype and glycine receptor deficient mice.	GLRA3 GLRA1	2.40e-05	3	99	2	17920294
Pubmed	The Cockayne syndrome B protein, involved in transcription-coupled DNA repair, resides in an RNA polymerase II-containing complex.	CSH1 CSH2	2.40e-05	3	99	2	9312053
Pubmed	Ribonucleotide reductase expression in cervical cancer: a radiation therapy oncology group translational science analysis.	RRM2B RRM1	2.40e-05	3	99	2	23552804
Pubmed	Ribonucleotide reduction is a cytosolic process in mammalian cells independently of DNA damage.	RRM2B RRM1	2.40e-05	3	99	2	18997010
Pubmed	The human growth hormone gene locus: structure, evolution, and allelic variations.	CSH1 CSH2	2.40e-05	3	99	2	3030680
Pubmed	In vitro characterization of enzymatic properties and inhibition of the p53R2 subunit of human ribonucleotide reductase.	RRM2B RRM1	2.40e-05	3	99	2	14729598
Pubmed	VEGFR-1, Bcl-2, and HO-1 Ratios in Pregnant Women With Hypertension.	FLT1 BCL2	2.40e-05	3	99	2	23925400
Pubmed	Comprehensive pathway-based analysis identifies associations of BCL2, GNAO1 and CHD2 with non-obstructive azoospermia risk.	CHD2 BCL2	2.40e-05	3	99	2	24549219
Pubmed	Blocking Bcl-2 resolves IL-13-mediated mucous cell hyperplasia in a Bik-dependent manner.	BCL2 BIK	2.40e-05	3	99	2	28784260
Pubmed	Characterization of enzymatic properties of human ribonucleotide reductase holoenzyme reconstituted in vitro from hRRM1, hRRM2, and p53R2 subunits.	RRM2B RRM1	2.40e-05	3	99	2	16376858
Pubmed	Late life metabolic syndrome, early growth, and common polymorphism in the growth hormone and placental lactogen gene cluster.	CSH1 CSH2	2.40e-05	3	99	2	15531513
Pubmed	Splicing variants of the human growth hormone mRNA: detection in pituitary, mononuclear cells and dermal fibroblasts.	CSH1 CSH2	2.40e-05	3	99	2	8674830
Pubmed	Autism-linked CHD gene expression patterns during development predict multi-organ disease phenotypes.	CHD2 CHD7	2.40e-05	3	99	2	30277262
Pubmed	Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study.	CHD2 SLC6A1	2.40e-05	3	99	2	23020937
Pubmed	Expression and mRNA splicing of glycine receptor subunits and gephyrin during neuronal differentiation of P19 cells in vitro, studied by RT-PCR and immunocytochemistry.	GLRA3 GLRA1	4.79e-05	4	99	2	9051263
Pubmed	Blk, a BH3-containing mouse protein that interacts with Bcl-2 and Bcl-xL, is a potent death agonist.	BCL2 BIK	4.79e-05	4	99	2	9525867
Pubmed	Laminin α2-mediated focal adhesion kinase activation triggers Alport glomerular pathogenesis.	COL4A3 PTK2	4.79e-05	4	99	2	24915008
Pubmed	Developmental control and alternative splicing of the placentally expressed transcripts from the human growth hormone gene cluster.	CSH1 CSH2	4.79e-05	4	99	2	1378436
Pubmed	The Bcl-2 family: roles in cell survival and oncogenesis.	BCL2 BIK	4.79e-05	4	99	2	14634621
Pubmed	Alpha subunit-dependent glycine receptor clustering and regulation of synaptic receptor numbers.	GLRA3 GLRA1	4.79e-05	4	99	2	28883437
Pubmed	CXCL8-induced FAK phosphorylation via CXCR1 and CXCR2: cytoskeleton- and integrin-related mechanisms converge with FAK regulatory pathways in a receptor-specific manner.	PTK2 CXCR1	4.79e-05	4	99	2	16406804
Pubmed	Identification of functional CCAAT/enhancer-binding protein and Ets protein binding sites in the human chorionic somatomammotropin enhancer sequences.	CSH1 CSH2	4.79e-05	4	99	2	21737519
Pubmed	The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53.	RRM2B RRM1	4.79e-05	4	99	2	14583450
Pubmed	Glycinergic input of widefield, displaced amacrine cells of the mouse retina.	GLRA3 GLRA1	4.79e-05	4	99	2	19528249
Pubmed	Activation of glycine receptor phase-shifts the circadian rhythm in neuronal activity in the mouse suprachiasmatic nucleus.	GLRA3 GLRA1	4.79e-05	4	99	2	21486797
Pubmed	The human growth hormone gene family: nucleotide sequences show recent divergence and predict a new polypeptide hormone.	CSH1 CSH2	4.79e-05	4	99	2	7169009
Pubmed	Induction of cell death by the BH3-only Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-dependent mitochondrial pathway.	BCL2 BIK	4.79e-05	4	99	2	12853473
Pubmed	The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions.	GRK2 CXCR1	4.79e-05	4	99	2	22869904
Pubmed	Essential role of Tip60-dependent recruitment of ribonucleotide reductase at DNA damage sites in DNA repair during G1 phase.	RRM2B RRM1	4.79e-05	4	99	2	20159953
Pubmed	Site-specific HNK-1 epitope on alternatively spliced fibronectin type-III repeats in tenascin-C promotes neurite outgrowth of hippocampal neurons through contactin-1.	B3GAT2 CNTN1	4.79e-05	4	99	2	30629639
Pubmed	Mammalian p53R2 protein forms an active ribonucleotide reductase in vitro with the R1 protein, which is expressed both in resting cells in response to DNA damage and in proliferating cells.	RRM2B RRM1	4.79e-05	4	99	2	11517226
Pubmed	Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits.	RRM2B RRM1	4.79e-05	4	99	2	12615712
Pubmed	Epithelial cell integrin β1 is required for developmental angiogenesis in the pituitary gland.	FLT1 CSH1 CSH2	5.55e-05	26	99	3	27810956
Pubmed	Role of prophet of Pit1 (PROP1) in gonadotrope differentiation and puberty.	ACVR1 CSH1 CSH2	6.23e-05	27	99	3	16384867
Pubmed	The human and mouse receptors for hyaluronan-mediated motility, RHAMM, genes (HMMR) map to human chromosome 5q33.2-qter and mouse chromosome 11.	CSH1 CSH2 GABRA6	6.23e-05	27	99	3	8595891
Pubmed	Central growth hormone action regulates metabolism during pregnancy.	CSH1 CSH2	7.98e-05	5	99	2	31479305
Pubmed	Molecular evolution of growth hormone and receptor in the guinea-pig, a mammal unresponsive to growth hormone.	CSH1 CSH2	7.98e-05	5	99	2	10767558
Pubmed	Rescue of pituitary function in a mouse model of isolated growth hormone deficiency type II by RNA interference.	CSH1 CSH2	7.98e-05	5	99	2	18006625
Pubmed	Growth hormone prevents the development of autoimmune diabetes.	CSH1 CSH2	7.98e-05	5	99	2	24218587
Pubmed	Body composition of inactivated growth hormone (oMt1a-oGH) transgenic mice: generation of an obese phenotype.	CSH1 CSH2	7.98e-05	5	99	2	9546108
Pubmed	Transgene transmission to progeny by oMt1a-oGH transgenic mice.	CSH1 CSH2	7.98e-05	5	99	2	16201410
Pubmed	Genes that prolong life: relationships of growth hormone and growth to aging and life span.	CSH1 CSH2	7.98e-05	5	99	2	11487592
Pubmed	Overexpressed growth hormone (GH) synergistically promotes carcinogen-initiated liver tumour growth by promoting cellular proliferation in emerging hepatocellular neoplasms in female and male GH-transgenic mice.	CSH1 CSH2	7.98e-05	5	99	2	11318985
Pubmed	Developmental regulation of glycine receptors at efferent synapses of the murine cochlea.	GLRA3 GLRA1	7.98e-05	5	99	2	21850450
Pubmed	Identification of the glomerular podocyte as a target for growth hormone action.	CSH1 CSH2	7.98e-05	5	99	2	17272398
Pubmed	Glucose homeostasis and insulin sensitivity in growth hormone-transgenic mice: a cross-sectional analysis.	CSH1 CSH2	7.98e-05	5	99	2	20707609
Pubmed	Induction of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice.	CSH1 CSH2	7.98e-05	5	99	2	1874564
Pubmed	Growth Hormone Deficiency and Excess Alter the Gut Microbiome in Adult Male Mice.	CSH1 CSH2	7.98e-05	5	99	2	32100023
Pubmed	Transgenic mice expressing bovine GH develop arthritic disorder and self-antibodies.	CSH1 CSH2	7.98e-05	5	99	2	10810296
Pubmed	Somatotropin transgenic mice have reduced jejunal active glucose transport rates.	CSH1 CSH2	7.98e-05	5	99	2	7965203
Pubmed	Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice.	CSH1 CSH2	7.98e-05	5	99	2	17347312
Pubmed	Pleiotropic effects of growth hormone signaling in aging.	CSH1 CSH2	7.98e-05	5	99	2	21852148
Pubmed	Body composition, bone mass and microstructural analysis in GH-transgenic mice reveals that skeletal changes are specific to bone compartment and gender.	CSH1 CSH2	7.98e-05	5	99	2	12175649
Pubmed	Native glycine receptor subtypes and their physiological roles.	GLRA3 GLRA1	7.98e-05	5	99	2	18721822
Pubmed	Transgenic mice reveal novel activities of growth hormone in wound repair, angiogenesis, and myofibroblast differentiation.	CSH1 CSH2	7.98e-05	5	99	2	15070902
Pubmed	A novel missense mutation in the mouse growth hormone gene causes semidominant dwarfism, hyperghrelinemia, and obesity.	CSH1 CSH2	7.98e-05	5	99	2	14726450
Pubmed	UV photodegradation of murine growth hormone: chemical analysis and immunogenicity consequences.	CSH1 CSH2	7.98e-05	5	99	2	24758742
Pubmed	Consequences of overexpression of growth hormone in transgenic mice on liver cytochrome P450 enzymes.	CSH1 CSH2	7.98e-05	5	99	2	10076541
Pubmed	Overgrowth of skin in growth hormone transgenic mice depends on the presence of male gonads.	CSH1 CSH2	7.98e-05	5	99	2	10594738
Pubmed	Hypoxia and cytoplasmic alkalinization upregulate growth hormone expression in lymphocytes.	CSH1 CSH2	7.98e-05	5	99	2	23639351
Pubmed	Pituitary growth hormone network responses are sexually dimorphic and regulated by gonadal steroids in adulthood.	CSH1 CSH2	7.98e-05	5	99	2	21098290
Pubmed	Age-related changes in body composition of bovine growth hormone transgenic mice.	CSH1 CSH2	7.98e-05	5	99	2	18948397
Pubmed	Heterogeneous growth hormone (GH) gene mutations in familial GH deficiency.	CSH1 CSH2	7.98e-05	5	99	2	8496314
Pubmed	Exploring endocrine GH pattern in mice using rank plot analysis and random blood samples.	CSH1 CSH2	7.98e-05	5	99	2	21045135
Pubmed	Analysis of gender difference of cardiac risk biomarkers using hGH-transgenic mice.	CSH1 CSH2	7.98e-05	5	99	2	16508206
Pubmed	Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia.	CSH1 CSH2	7.98e-05	5	99	2	15616010
Pubmed	Nitric oxide stimulates embryonic somatotroph differentiation and growth hormone mRNA and protein expression through a cyclic guanosine monophosphate-independent mechanism.	CSH1 CSH2	7.98e-05	5	99	2	19019400
Pubmed	The Effects of 20-kDa Human Placental GH in Male and Female GH-deficient Mice: An Improved Human GH?	CSH1 CSH2	7.98e-05	5	99	2	32556100
Pubmed	High frequency of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice created from two different strains of mice.	CSH1 CSH2	7.98e-05	5	99	2	1525063
GeneFamily	DNA helicases	CHD2 CHD7 INO80	2.52e-05	17	62	3	1167
GeneFamily	Glycine receptors	GLRA3 GLRA1	1.15e-04	5	62	2	868
GeneFamily	Growth hormone family	CSH1 CSH2	1.72e-04	6	62	2	1175
GeneFamily	Olfactory receptors, family 52	OR52R1 OR52K1 OR52K2	6.32e-04	49	62	3	165
GeneFamily	Anaphase promoting complex \|Tetratricopeptide repeat domain containing	ANAPC1 CDC23	1.03e-03	14	62	2	402
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	FLT1 IGSF10 PXDNL CNTN1	2.26e-03	161	62	4	593
Computational	Neurotransmitter (GABA) receptor.	GLRA3 GLRA1 GABRA6	5.52e-05	15	55	3	MODULE_215
Drug	isoguvacine	GLRA3 SLC6A1 GLRA1 CXCR1 GABRA6	1.28e-06	45	96	5	CID000003765
Drug	Ioxaglic acid [59017-64-0]; Down 200; 3.2uM; HL60; HT_HG-U133A	MAGEB2 FLT1 DHRS3 ERAP1 PTK2 GPR107 RUSC2 PKN2	1.75e-06	195	96	8	2966_DN
Drug	Hydrocortisone base [50-23-7]; Down 200; 11uM; PC3; HT_HG-U133A	CHD7 ZNF442 KPTN CEMIP GRK2 TELO2 PDE4DIP MFSD10	1.81e-06	196	96	8	6684_DN
Drug	Blue Shield	GLRA3 DHDH GLRA1 CXCR1	7.48e-06	30	96	4	CID000014830
Drug	sodium chloride	COL4A3 SMARCA5 BCL2 ST3GAL3 ALG10B GRK2 PIGA DHDH MOGS CSH2 LPO A4GNT PKN2 B3GAT2	1.56e-05	865	96	14	CID000000206
Drug	AC1L2O7O	RRM2B RRM1	1.76e-05	2	96	2	CID000075180
Drug	tris(tetrabutylammonium) hydrogen pyrophosphate	RRM2B RRM1	1.76e-05	2	96	2	CID011115639
Drug	2-amino-1-hydroxyguanidine	RRM2B RRM1	1.76e-05	2	96	2	CID005464082
Drug	SureCN843110	RRM2B RRM1	1.76e-05	2	96	2	CID014570995
Drug	v 1394	RRM2B RRM1	1.76e-05	2	96	2	CID000101484
Drug	16-phenyl tetranor Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A	SMARCA5 ARFGEF1 ACVR1 DBT RRM1 F8 PDE4DIP	1.90e-05	195	96	7	7509_DN
Drug	Pronethalol hydrochloride [51-02-5]; Up 200; 15uM; HL60; HT_HG-U133A	FLT1 ACACB ABCA7 GPR107 PIEZO2 GRK2 CNTN1	2.10e-05	198	96	7	2902_UP
Drug	Adenosine phosphonoacetic acid	RRM2B RRM1	5.26e-05	3	96	2	CID000448505
Drug	2'-deoxytoyocamycin	RRM2B RRM1	5.26e-05	3	96	2	CID000204132
Drug	1-amino-3-hydroxyguanidine	RRM2B RRM1	5.26e-05	3	96	2	CID009571038
Drug	Bild 1351	RRM2B RRM1	5.26e-05	3	96	2	CID005478827
Drug	beta-dimethylaminopropiophenone	RRM2B RRM1	5.26e-05	3	96	2	CID000077042
Drug	hydroxyguanidine sulfate	RRM2B RRM1	5.26e-05	3	96	2	CID000080667
Drug	2D ABR	RRM2B RRM1	5.26e-05	3	96	2	CID000125209
Drug	6-aminothymine	RRM2B RRM1	5.26e-05	3	96	2	CID000065245
Drug	cyclo(Sar-Sar	RRM2B RRM1	5.26e-05	3	96	2	CID000078761
Drug	AC1N8OVF	RRM2B RRM1	5.26e-05	3	96	2	CID004347182
Drug	2'-chloro-2'-dudp	RRM2B RRM1	5.26e-05	3	96	2	CID003082518
Drug	3,4-dihydroxybenzaldoxime	RRM2B RRM1	5.26e-05	3	96	2	CID005388593
Drug	NSC-137029	RRM2B RRM1	5.26e-05	3	96	2	CID000421633
Drug	Bild 1357	RRM2B RRM1	5.26e-05	3	96	2	CID000515298
Drug	2'-azido-2'-deoxycytidine 5'-diphosphate	RRM2B RRM1	5.26e-05	3	96	2	CID000170963
Drug	AC1LAKEY	RRM2B RRM1	5.26e-05	3	96	2	CID000515340
Drug	Val-Val-Asn-Asp-Leu	RRM2B RRM1	5.26e-05	3	96	2	CID000515343
Drug	dial-CDP	RRM2B RRM1	5.26e-05	3	96	2	CID005487791
Drug	clofarabine	AADAC RRM2B BCL2 RRM1	5.89e-05	50	96	4	CID000119182
Drug	5,6-dimethylbenzimidazole	RRM2B RRM1 CNTN1	6.70e-05	19	96	3	CID000000675
Drug	di-Z	GLRA3 SLC6A1 GLRA1	7.86e-05	20	96	3	CID000656933
Drug	R 5135	GLRA3 GLRA1 GABRA6	9.14e-05	21	96	3	CID000119544
Drug	nipecotic acid	GLRA3 SLC6A1 GLRA1 GABRA6	9.88e-05	57	96	4	CID000004498
Drug	2-formylpyridine thiosemicarbazonato copper(II	RRM2B RRM1	1.05e-04	4	96	2	CID009576822
Drug	4-nitro-benzohydrazide	RRM2B RRM1	1.05e-04	4	96	2	CID003693744
Drug	protostrychnine	GLRA3 GLRA1	1.05e-04	4	96	2	CID005320746
Drug	7-nitroindoline	GLRA3 GLRA1	1.05e-04	4	96	2	CID013566747
Drug	SC-49648	GLRA3 GLRA1	1.05e-04	4	96	2	CID000195696
Drug	akuammiline	GLRA3 GLRA1	1.05e-04	4	96	2	CID005367018
Drug	N-methyl-THIP	GLRA3 GLRA1	1.05e-04	4	96	2	CID000134373
Drug	SC-48981	GLRA3 GLRA1	1.05e-04	4	96	2	CID000126573
Drug	p-propoxyphenol	RRM2B RRM1	1.05e-04	4	96	2	CID000029352
Drug	Dacisteine	RRM2B RRM1	1.05e-04	4	96	2	CID000065690
Drug	iso-THAZ	GLRA3 GLRA1	1.05e-04	4	96	2	CID003047783
Drug	AC1O7EGN	RRM2B RRM1	1.05e-04	4	96	2	CID006446439
Drug	2-(phosphonomethyl)phenylalanine	GLRA3 GLRA1	1.05e-04	4	96	2	CID000383689
Drug	BPYTA	RRM2B RRM1	1.05e-04	4	96	2	CID003034633
Drug	NSC381080	GLRA3 GLRA1	1.05e-04	4	96	2	CID000165497
Drug	NS 1619	FLT1 BCL2	1.05e-04	4	96	2	ctd:C086491
Drug	2-formylpyridine thiosemicarbazone	RRM2B RRM1	1.05e-04	4	96	2	CID001638752
Drug	SC-50132	GLRA3 GLRA1	1.05e-04	4	96	2	CID000195719
Drug	SR 42641	GLRA3 GLRA1	1.05e-04	4	96	2	CID000129049
Drug	2'-azido-2'-deoxyuridine	RRM2B RRM1	1.05e-04	4	96	2	CID000168629
Drug	AC1NUW81	RRM2B RRM1 CNTN1	1.06e-04	22	96	3	CID005462220
Drug	2-formylpyridine	RRM2B RRM1 DHDH	1.06e-04	22	96	3	CID000014273
Drug	F-ara-ATP	RRM2B PTDSS1 RRM1	1.06e-04	22	96	3	CID000126498
Drug	SR 95531	GLRA3 SLC6A1 GLRA1 GABRA6	1.13e-04	59	96	4	CID000005275
Drug	Isoflurophate	AADAC BCL2 NCEH1	1.38e-04	24	96	3	ctd:D007531
Drug	SL 75102	GLRA3 GLRA1 GABRA6	1.38e-04	24	96	3	CID005751746
Drug	AP-7	GLRA3 GLRA1 MOV10L1 GABRA6	1.46e-04	63	96	4	CID000003122
Drug	isonipecotic acid	SLC6A1 GLRA1 GABRA6	1.56e-04	25	96	3	CID000003773
Drug	CCD 1042	NPC1 SLC6A1 GABRA6	1.56e-04	25	96	3	CID000038022
Drug	Mesalamine [89-57-6]; Down 200; 26.2uM; HL60; HT_HG-U133A	ERAP1 ARFGEF1 DBT RUSC2 BIK TMEM260	1.64e-04	192	96	6	6162_DN
Drug	picrotoxinine	GLRA3 CLIC6 GLRA1 GABRA6	1.65e-04	65	96	4	CID000004816
Drug	Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; PC3; HT_HG-U133A	FLT1 GPR107 RUSC2 GRK2 MOGS PDE4DIP	1.69e-04	193	96	6	4285_DN
Drug	NSC23615	SLC24A5 RRM2B GCH1 BCL2 RRM1 GABRA6	1.69e-04	193	96	6	CID000000640
Drug	motropin	RRM2B RRM1	1.74e-04	5	96	2	CID000064657
Drug	Lindane	GLRA3 GLRA1	1.74e-04	5	96	2	DB00431
Drug	A1110U	RRM2B RRM1	1.74e-04	5	96	2	CID003006964
Drug	3,4-DHPA	GCH1 DHDH	1.74e-04	5	96	2	CID000134092
Drug	2-methylene-3-furanone	RRM2B RRM1	1.74e-04	5	96	2	CID000124504
Drug	348U87	RRM2B RRM1	1.74e-04	5	96	2	CID003006985
Drug	mdGuo	RRM2B RRM1	1.74e-04	5	96	2	CID000126596
Drug	acetylpyrazine	RRM2B RRM1	1.74e-04	5	96	2	CID000030914
Drug	MdAdo	RRM2B RRM1	1.74e-04	5	96	2	CID000175972
Drug	pleiocarpamine	GLRA3 GLRA1	1.74e-04	5	96	2	CID000558637
Drug	azetidine-3-carboxylic acid	GLRA3 GLRA1	1.74e-04	5	96	2	CID000093192
Drug	Cao C	GLRA3 GLRA1	1.74e-04	5	96	2	CID000166617
Drug	AC1NQVLK	RRM2B RRM1	1.74e-04	5	96	2	CID002732427
Drug	oxanilide	GLRA3 GLRA1	1.74e-04	5	96	2	CID000069288
Drug	2-hydroxy-1-naphthylaldehyde benzoyl hydrazone	RRM2B RRM1	1.74e-04	5	96	2	CID005384003
Drug	p-butoxyphenol	RRM2B RRM1	1.74e-04	5	96	2	CID000031233
Drug	iso-THAO	GLRA3 GLRA1	1.74e-04	5	96	2	CID000127199
Drug	bruceine	RRM2B RRM1	1.74e-04	5	96	2	CID000122785
Drug	ALX1393	GLRA3 GLRA1	1.74e-04	5	96	2	CID016078939
Drug	N-hydroxy-N'-methylurea	RRM2B RRM1	1.74e-04	5	96	2	CID000096412
Drug	mafoprazine	GLRA3 GLRA1	1.74e-04	5	96	2	CID000071241
Drug	gevotroline	GLRA3 GLRA1	1.74e-04	5	96	2	CID000060546
Drug	Citrusinine-I	RRM2B RRM1	1.74e-04	5	96	2	CID005487772
Drug	V-X-A	GLRA3 GLRA1 GABRA6	1.76e-04	26	96	3	CID006369389
Drug	Minaprine dihydrochloride [25953-17-7]; Down 200; 10.8uM; HL60; HG-U133A	SMARCA5 ARFGEF1 DBT GPR107 KPTN ARMH3	1.79e-04	195	96	6	1968_DN
Drug	Pivmecillinam hydrochloride [32887-03-9]; Down 200; 8.4uM; HL60; HT_HG-U133A	FLT1 DHRS3 ERAP1 KPTN PDE4DIP ARMH3	1.79e-04	195	96	6	2973_DN
Drug	Napelline [5008-52-6]; Up 200; 11.2uM; MCF7; HT_HG-U133A	DBT RUSC2 CEMIP GRK2 PDE4DIP PCNX1	1.84e-04	196	96	6	6824_UP
Drug	tetraethylenepentamine pentahydrochloride; Down 200; 100uM; HL60; HG-U133A	ACACB KCNB2 GPR107 PIEZO2 ECE2 CNTN1	1.84e-04	196	96	6	412_DN
Drug	D-cycloserine [68-41-7]; Down 200; 39.2uM; MCF7; HT_HG-U133A	VPS54 ZNF442 F8 KPTN MOGS PCNX1	1.84e-04	196	96	6	6782_DN
Drug	trans-4-aminocrotonic acid	CLIC6 SLC6A1 CXCR1 GABRA6	1.86e-04	67	96	4	CID000002766
Drug	Sulfadiazine [68-35-9]; Down 200; 16uM; PC3; HT_HG-U133A	ERAP1 DBT KPTN GRK2 PCNX1 MFSD10	1.89e-04	197	96	6	5098_DN
Drug	Solasodine [126-17-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A	AADAC ERAP1 ABCA7 RUSC2 PIEZO2 A4GNT	1.94e-04	198	96	6	6025_UP
Disease	Myoclonic-astatic epilepsy	CHD2 SLC6A1	3.14e-05	3	96	2	cv:C0393702
Disease	osteoporosis (biomarker_via_orthology)	BCL2 CSH1 CSH2	4.91e-05	22	96	3	DOID:11476 (biomarker_via_orthology)
Disease	lactosyl-N-palmitoyl-sphingosine (d18:1/16:0) measurement	CHD7 ABCA7	1.04e-04	5	96	2	EFO_0800429
Disease	isolated growth hormone deficiency type II (implicated_via_orthology)	CSH1 CSH2	1.04e-04	5	96	2	DOID:0060872 (implicated_via_orthology)
Disease	CHARGE syndrome (implicated_via_orthology)	CHD2 CHD7	2.18e-04	7	96	2	DOID:0050834 (implicated_via_orthology)
Disease	isolated growth hormone deficiency (implicated_via_orthology)	CSH1 CSH2	2.18e-04	7	96	2	DOID:0060870 (implicated_via_orthology)
Disease	ductal carcinoma in situ (is_marker_for)	FLT1 BCL2 PTK2	2.80e-04	39	96	3	DOID:0060074 (is_marker_for)
Disease	severe pre-eclampsia (is_marker_for)	ERAP1 ACVR1	2.90e-04	8	96	2	DOID:13129 (is_marker_for)
Disease	lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) measurement	CHD7 ABCA7	3.72e-04	9	96	2	EFO_0800517
Disease	Thromboembolism	OR51E2 OR52K1 OR52K2	4.01e-04	44	96	3	HP_0001907
Disease	congestive heart failure (biomarker_via_orthology)	GCH1 BCL2 GRK2 DIO3	4.20e-04	107	96	4	DOID:6000 (biomarker_via_orthology)
Disease	Myoclonic Astatic Epilepsy	CHD2 SLC6A1	5.65e-04	11	96	2	C0393702
Disease	Seizures	RRM2B GCH1 DBT KPTN SLC6A1	7.45e-04	218	96	5	C0036572
Disease	Connective Tissue Diseases	ACVR1 PIEZO2	7.98e-04	13	96	2	C0009782
Disease	hip bone mineral density, hip bone size	ALG10B TMEM260 OR52K2	8.16e-04	56	96	3	EFO_0004844, EFO_0007702
Disease	congenital hypothyroidism (biomarker_via_orthology)	CSH1 CSH2	9.29e-04	14	96	2	DOID:0050328 (biomarker_via_orthology)
Disease	impotence (implicated_via_orthology)	BCL2 GRK2	1.07e-03	15	96	2	DOID:1875 (implicated_via_orthology)
Disease	Spondyloepiphyseal Dysplasia	FLT1 BCL2	1.22e-03	16	96	2	C0038015
Disease	Spondyloepiphyseal Dysplasia Tarda, X-Linked	FLT1 BCL2	1.22e-03	16	96	2	C3541456
Disease	Schwartz-Jampel Syndrome, Type 1	FLT1 BCL2	1.22e-03	16	96	2	C4551479
Disease	Schwartz-Jampel Syndrome	FLT1 BCL2	1.22e-03	16	96	2	C0036391
Disease	Melnick-Needles Syndrome	FLT1 BCL2	1.22e-03	16	96	2	C0025237
Disease	hip bone size	ALG10B TMEM260 OR52K2	1.26e-03	65	96	3	EFO_0004844
Disease	glycochenodeoxycholate measurement	CEMIP GRK2	1.38e-03	17	96	2	EFO_0010490
Disease	Van Buchem disease	FLT1 BCL2	1.38e-03	17	96	2	C0432272
Disease	MHPG measurement, 5-HIAA measurement	COL4A3 PIEZO2	1.38e-03	17	96	2	EFO_0005132, EFO_0005133
Disease	Osteochondrodysplasias	FLT1 BCL2	1.73e-03	19	96	2	C0029422
Disease	Dyschondroplasias	FLT1 BCL2	1.73e-03	19	96	2	C0013366
Disease	Multiple Epiphyseal Dysplasia	FLT1 BCL2	1.92e-03	20	96	2	C0026760
Disease	Disease Exacerbation	FLT1 BCL2 RRM1 ABCA7	2.10e-03	165	96	4	C0235874
Disease	portal hypertension (biomarker_via_orthology)	GCH1 GRK2	2.32e-03	22	96	2	DOID:10762 (biomarker_via_orthology)
Disease	Autism Spectrum Disorders	CHD2 DIO3 USH2A	2.72e-03	85	96	3	C1510586
Disease	West Syndrome	ST3GAL3 PIGA	2.76e-03	24	96	2	C0037769
Disease	endometriosis (is_marker_for)	BCL2 PTK2	2.99e-03	25	96	2	DOID:289 (is_marker_for)
Disease	pseudotumor cerebri	KCNB2 CXCR1	3.24e-03	26	96	2	EFO_1001132

Protein segments in the cluster

Peptide	Gene	Start	Entry
FLSLPDTWMKEFFLA	CDC23	221	Q9UJX2
FWLASLNPERMFRKP	COL4A3	1631	Q01955
WKMIASHRFSSPFLK	BRD8	1116	Q9H0E9
SNFLFLSKSLMVRFW	AADAC	236	P22760
RPMFKLAWTPFLAAF	ARFGEF1	946	Q9Y6D6
MKRLLEDTPLFSWYN	A4GNT	121	Q9UNA3
WFSDPTLTSLAKLMK	ACVR1	461	Q04771
CSPRFWEELFLMKVN	ARMH3	41	Q5T2E6
DSLKSKPIFWNLMFF	ALG10B	386	Q5I7T1
NCPFSQRLFMILWLK	CLIC6	486	Q96NY7
FTTLKENIMRFWRSP	BIK	111	Q13323
RQDFLFKAMLTISWL	CEMIP	6	Q8WUJ3
AFSFWPKDRVMINRL	CHD7	2306	Q9P2D1
LFIFWKEMPEDRAST	ATP2C2	821	O75185
MDPSARRFLWNSLLA	ABCA7	1956	Q8IZY2
PFFRSLDWQMVFLQK	GRK2	451	P25098
WLMAALPFTKSLSLV	GPR107	296	Q5VW38
SMLDSIWKPDLFFAN	GLRA3	121	O75311
FWKRALPFSLVSMLV	OCIAD2	51	Q56VL3
LWALLHFIMPTLFDS	INO80	691	Q9ULG1
REKLPLMIFANWRGF	ACACB	2146	O00763
WLRAPDTMYLLDFVK	ANAPC1	1386	Q9H1A4
LWKSYLENPAFMLLD	DBT	466	P11182
EMAPWFALLFAASDL	MFSD10	201	Q14728
LASLASFKMDPLISW	HHATL	146	Q9HCP6
MLSLAAKLVAFFWRT	MOV10L1	1	Q9BXT6
SLLSSWDFPRRKLLM	MAGEB2	191	O15479
EFLWGPRAFLETSKM	MAGEL2	1181	Q9UJ55
PWFQRAKMPRALDFS	IFNLR1	256	Q8IU57
MEFGLSWIFLAAILK	IGHV3-15	1	A0A0B4J1V0
LVLFPRFLGTAFMLW	DIO3	46	P55073
LSWKRMAGIFFLPFI	GLB1L3	11	Q8NCI6
FVRNLPFDFTWKMLK	HNRNPM	656	P52272
SWLEPVRFLRSMFAN	CSH2	111	P0DML3
SMDWLEFLSFLLSPL	ECE2	386	P0DPD6
MVFLPLKWSLATMSF	ERAP1	1	Q9NZ08
DLFFMSILFNKLWEL	PCNX1	1436	Q96RV3
LLWQRSFSSPLLAMA	KPTN	356	Q9Y664
ALSTSTMPKILALFW	OR51E2	71	Q9H255
TMPKILALFWFDSRE	OR51E2	76	Q9H255
NLAFLDMWLASFATP	OR4K14	66	Q8NGD5
LPLHTLFFNTWRMVK	LPO	491	P22079
SVSDPWKLMLLDATF	NCEH1	26	Q6PIU2
LMVSKIWTPDTFFRN	GABRA6	106	Q16445
FKMLFLPESARWIQR	F8	1116	P00451
LRMFASWLFKAATLP	RALGAPA2	991	Q2PPJ7
PLLTEMVKSRLNSWF	MOGS	271	Q13724
LLRYFSWAEPQLKAM	PROSER1	41	Q86XN7
FKNSYSPLLLKDWMR	NPC1	821	O15118
LSSSTQPKMLAIFWF	OR52R1	76	Q8NGF1
FDLINGKPFRLMWSQ	PABPC5	81	Q96DU9
MEPRLFCWTTLFLLA	PXDNL	1	A1KZ92
FWPAKLQASSRVVMF	CPLANE2	96	Q9BU20
PKIFWLLPSNDMISF	IGSF10	2171	Q6WRI0
MEYLLRFLSSPNKWK	KCNB2	246	Q92953
LWSLLHFIMPEKFEF	CHD2	656	O14647
MKSALFTRFFILLPW	B3GAT2	1	Q9NPZ5
RWLLNEFPVFITMDK	CNTN1	171	Q12860
WGLSMNLSLPFFLFR	CXCR1	161	P25024
AWLFLFSKFIELMDT	ELOVL1	111	Q9BW60
FQKPFQTLMFLVRDW	ATL3	201	Q6DD88
FAARWRSKAPMSLFL	BPIFB6	341	Q8NFQ5
MEFGLSWLFLVAILK	IGHV3-23	1	P01764
RALFLMEAIWTRFFP	DHDH	116	Q9UQ10
SWLEPVRFLRSMFAN	CSH1	111	P0DML2
QFWTTKAFLPRMLEL	DHRS3	151	O75911
FSLTFFKRRMWPLAF	MICOS10	31	Q5TGZ0
SSTTLPKMLAIFWFR	OR52K1	76	Q8NGK4
SSSALPKMLAIFWFR	OR52K2	76	Q8NGK3
PKMLAIFWFRDREIN	OR52K2	81	Q8NGK3
PSDWLSLDKSMFQLV	RUSC2	1406	Q8N2Y8
SPKLMASFTLAVWLK	USH2A	141	O75445
LFSWDTVFKLLAIAM	TMEM41A	216	Q96HV5
LLDSIFWMAAPKNRR	MRPL32	71	Q9BYC8
LPDRDTWKGRFDFLM	SLC6A1	41	P30531
IKWMAPESINFRRFT	PTK2	586	Q05397
SMLDSIWKPDLFFAN	GLRA1	116	P23415
LLKTPWRAASAMQFF	GCH1	91	P30793
FLWMELRFNTLAKCP	PIP4P2	161	Q8N4L2
MWALSPTVFALLSKN	SMG1	631	Q96Q15
APMFLDDSFRKWARI	ST3GAL3	106	Q11203
AMGKALLEFVWALRF	TELO2	746	Q9Y4R8
KKHPFFRLIDWSALM	PKN2	911	Q16513
MRPLFDFSWLSLKTL	BCL2	206	P10415
MLWRFISLFSELEAK	C17orf64	111	Q86WR6
FLFLIFLRWMTPDSI	PIGA	436	P37287
SFAAIFWLKKRGLMP	RRM2B	201	Q7LG56
RDLFFALWIPDLFMK	RRM1	326	P23921
PSWNKDLRLLFDQFM	THEM4	51	Q5T1C6
GEMLRSFLTKLEWFS	PRPF38B	201	Q5VTL8
VWFPLLFMSLIKSVA	PIEZO2	2416	Q9H5I5
FNMPEADLKRIFWVL	SLC24A5	296	Q71RS6
KAFFWPSLFRMHERT	ZNF442	216	Q9H7R0
LEFEKMLPEWLRSRF	TRPV3	701	Q8NET8
PQFRFDWFLKSRTAM	SMARCA5	981	O60264
SSTLLASPMLKRFTW	FLT1	1246	P17948
PFDRFDAAKFVMRWL	ZYG11A	461	Q6WRX3
WELTELFFMHLLPNF	PTDSS1	196	P48651
EMWPSLLLAIKTANF	TOE1	46	Q96GM8
FAWRANLDISKPLFM	TMEM260	336	Q9NX78
MLNFPQWFDLLKDIF	VPS54	441	Q9P1Q0
ESASLLTMFWRAALP	PDE4DIP	2246	Q5VU43